Article
A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences
17 Jul 2013
Abstract excerpt
INTRODUCTION: Breast cancer risk of recurrence is known to span 20 years, yet existing prognostic signatures are best at predicting early recurrences (≤ 5 years). There is a critical need to identify those patients at risk of late-relapse (>5 years), in order to select potential candidates for further treatment and to identify molecular targets for such treatment. METHODS: A total of 252 breast primary tumors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
